Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to sell Apixio, a leading artificial intelligence platform that enables value-based care, to New Mountain Capital, a growth-oriented investment firm with more than $37 billion in assets under management. Centene acquired Apixio in December 2020. Apixio improves administrative, clinical and financial outcomes for some of the nation’s leading health plans and provider groups using its proprietary clinical data curation and artificial intelligence engine. With a patented data science infrastructure, Apixio analyzes structured and unstructured data to develop high-fidelity patient health profiles and support value-based care programs.
Read the full article: Centene Corporation Signs Definitive Agreement to Divest Apixio to New Mountain Capital //
Source: https://www.prnewswire.com/news-releases/centene-corporation-signs-definitive-agreement-to-divest-apixio-to-new-mountain-capital-301814246.html